Insider Trading May 12, 2026 05:19 PM

Arteris CEO Charles Janac Executes $2.18 Million Stock Sale via Pre-Arranged Plan

The transaction occurs as Arteris shares trade near 52-week highs following a significant annual surge, despite ongoing profitability challenges.

By Leila Farooq AIP

Charles K. Janac, the President and Chief Executive Officer of Arteris, Inc. (NASDAQ: AIP), has completed a sale of 70,000 shares of the company's common stock. The transaction, which took place on May 8, 2026, resulted in total proceeds of $2,183,986. The shares were liquidated at varying prices between $29.19 and $32.07 per share, maintaining a weighted average sale price of $31.1998.This divestment follows a period of intense stock appreciation for Arteris, which has seen its share price climb by 321% over the last year. At the time of the reporting, the stock was trading at $32.43, positioned close to its 52-week high of $33.46. While the company's market capitalization stands at $1.53 billion, it continues to report an earnings per share (EPS) of -$0.82, reflecting a lack of profitability.

Arteris CEO Charles Janac Executes $2.18 Million Stock Sale via Pre-Arranged Plan
AIP

Key Points

  • CEO Charles Janac sold 70,000 shares via a 10b5-1 plan for over $2.18 million.
  • Arteris reported Q1 2026 revenue of $22.94 million and EPS of -$0.03, both beating forecasts.
  • The stock has surged 321% over the past year but faces questions regarding being overvalued.

In a notable move regarding executive equity, Charles K. Janac, President and Chief Executive Officer of Arteris, Inc. (NASDAQ: AIP), sold 70,000 shares of common stock on May 8, 2026. The total value realized from this transaction was $2,183,986. According to transaction records, the sale was executed at prices ranging from a low of $29.19 to a high of $32.07 per share, resulting in a weighted average price of $31.1998.

The timing of this sale coincides with significant recent momentum for Arteris stock. The company's shares have experienced a 321% surge over the past year and were trading at $32.43 at the time of the report, which is near its 52-week high of $33.46. Analysis suggests that the stock may be considered overvalued at these current levels.

The sale was conducted indirectly through Bayview Legacy, LLC. Mr. Janac serves as the manager of this entity and holds both voting and dispositive power over the shares in question. This transaction was not an impromptu market move but was carried out pursuant to a pre-arranged 10b5-1 trading plan that Mr. Janac had established on March 5, 2025.

Following the completion of this sale, Mr. Janac's indirect holdings via Bayview Legacy, LLC, amount to 9,049,071 shares of Arteris common stock. Additionally, he maintains a direct holding of 196,729 shares. He also holds an indirect interest in 56,252 shares through the Charles and Lydia Janac Trust, for which he acts as trustee.


Key Market Insights

Executive Equity Movement: The execution of a 10b5-1 plan by a high-ranking executive like the CEO provides clarity on the structured nature of the sale. This type of transaction is pre-planned, often to avoid conflicts regarding market timing.

Revenue and Earnings Performance: Despite current unprofitability, Arteris recently demonstrated strength in its first quarter of 2026. The company reported revenue of $22.94 million, which exceeded the expected $21.03 million. Furthermore, its earnings per share (EPS) of -$0.03 outperformed the forecasted -$0.07, suggesting a trend of meeting or exceeding market expectations in recent operational cycles.

Sector Impact: Such movements within semiconductor and tech-adjacent components can influence broader investor sentiment regarding growth stocks that are currently navigating the path from high revenue growth toward stabilized profitability.


Risks and Uncertainties

Valuation Discrepancies: While the stock has seen a massive 321% increase, there is an identified risk regarding current valuation. Analysts suggest the stock may be overvalued at its present price levels, which could lead to volatility.

Profitability Constraints: A primary uncertainty for investors remains the company's bottom line. Arteris currently carries a market capitalization of $1.53 billion while maintaining an EPS of -$0.82, highlighting the ongoing challenge of achieving consistent profitability despite revenue growth.

Market Volatility: Even following positive earnings surprises in the first quarter of 2026, the stock experienced declines in aftermarket trading, illustrating that exceeding expectations does not always guarantee immediate upward price movement in the semiconductor and tech sectors.

Risks

  • Ongoing lack of profitability with an EPS of -$0.82.
  • Potential overvaluation following a massive 321% annual price surge.
  • Market volatility evidenced by aftermarket declines despite earnings beats.

More from Insider Trading

Phillips 66 CFO Executes $5.1 Million Stock Sale Following Domestic Relations Order May 12, 2026 Texas Instruments Executive Executes $1.46 Million Stock Sale Amid Recent Price Surge May 12, 2026 Bayview Legacy, LLC Reduces Position in Arteris, Inc. via Pre-Arranged Trading Plan May 12, 2026 Bridgewater Bancshares Director Mary Jayne Crocker Increases Position via Preferred Stock Purchase May 12, 2026 Funko Executive Executes Stock Sale Amid Recent Price Surge May 12, 2026